204 related articles for article (PubMed ID: 22388630)
1. Rationale for the use of radiolabelled peptides in diagnosis and therapy.
Koopmans KP; Glaudemans AW
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S4-10. PubMed ID: 22388630
[TBL] [Abstract][Full Text] [Related]
2. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
Sosabowsky J; Melendez-Alafort L; Mather S
Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415
[TBL] [Abstract][Full Text] [Related]
3. Radiolabelled peptides for oncological diagnosis.
Laverman P; Sosabowski JK; Boerman OC; Oyen WJ
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1(Suppl 1):S78-92. PubMed ID: 22388627
[TBL] [Abstract][Full Text] [Related]
4. Radiopharmaceutical development of radiolabelled peptides.
Fani M; Maecke HR
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S11-30. PubMed ID: 22388624
[TBL] [Abstract][Full Text] [Related]
5. Radiolabelled peptides in diagnosis and therapy: an introduction.
AL-Nahhas A; Fanti S
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S1-3. PubMed ID: 22388632
[No Abstract] [Full Text] [Related]
6. Radiolabeled peptides in the diagnosis and therapy of oncological diseases.
Weiner RE; Thakur ML
Appl Radiat Isot; 2002 Nov; 57(5):749-63. PubMed ID: 12433051
[TBL] [Abstract][Full Text] [Related]
7. Peptide radiopharmaceuticals for diagnosis and therapy.
Signore A; Annovazzi A; Chianelli M; Corsetti F; Van de Wiele C; Watherhouse RN
Eur J Nucl Med; 2001 Oct; 28(10):1555-65. PubMed ID: 11685500
[TBL] [Abstract][Full Text] [Related]
8. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.
Okarvi SM
Cancer Treat Rev; 2008 Feb; 34(1):13-26. PubMed ID: 17870245
[TBL] [Abstract][Full Text] [Related]
9. Current status and perspectives in peptide receptor radiation therapy.
Ansquer C; Kraeber-Bodéré F; Chatal JF
Curr Pharm Des; 2009; 15(21):2453-62. PubMed ID: 19601842
[TBL] [Abstract][Full Text] [Related]
10. Radiopeptide imaging and therapy in Europe.
Ambrosini V; Fani M; Fanti S; Forrer F; Maecke HR
J Nucl Med; 2011 Dec; 52 Suppl 2():42S-55S. PubMed ID: 22144555
[TBL] [Abstract][Full Text] [Related]
11. Peptide radiopharmaceuticals in diagnosis and therapy of cancer and inflammation/infection. Proceedings of the 16th IRIST (International Research Group on Immunoscintigraphy and Therapy) Congress. May 8-10, 2003.
Cancer Biother Radiopharm; 2004 Feb; 19(1):55-134. PubMed ID: 15068611
[No Abstract] [Full Text] [Related]
12. Imaging tumors with peptide-based radioligands.
Behr TM; Gotthardt M; Barth A; Béhé M
Q J Nucl Med; 2001 Jun; 45(2):189-200. PubMed ID: 11476170
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeled peptides in oncology: role in diagnosis and treatment.
Weiner RE; Thakur ML
BioDrugs; 2005; 19(3):145-63. PubMed ID: 15984900
[TBL] [Abstract][Full Text] [Related]
14. Tumor imaging and therapy using radiolabeled somatostatin analogues.
de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
[TBL] [Abstract][Full Text] [Related]
15. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy.
de Visser M; Verwijnen SM; de Jong M
Cancer Biother Radiopharm; 2008 Apr; 23(2):137-57. PubMed ID: 18454684
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes.
Smith CJ; Volkert WA; Hoffman TJ
Nucl Med Biol; 2005 Oct; 32(7):733-40. PubMed ID: 16243649
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeled peptides in diagnosis and therapy.
Weiner RE; Thakur ML
Semin Nucl Med; 2001 Oct; 31(4):296-311. PubMed ID: 11710772
[TBL] [Abstract][Full Text] [Related]
19. Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy.
Panigone S; Nunn AD
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):310-21. PubMed ID: 17043628
[TBL] [Abstract][Full Text] [Related]
20. Candidates for peptide receptor radiotherapy today and in the future.
Reubi JC; Mäcke HR; Krenning EP
J Nucl Med; 2005 Jan; 46 Suppl 1():67S-75S. PubMed ID: 15653654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
